Found: 7
Select item for more details and to access through your institution.
Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 12, p. 2545, doi. 10.1007/s00432-017-2504-5
- By:
- Publication type:
- Article
Impact of hand-foot skin reaction on treatment outcome in patients receiving capecitabine plus erlotinib for advanced pancreatic cancer: A subgroup analysis from AIO-PK0104.
- Published in:
- Acta Oncologica, 2015, v. 54, n. 7, p. 993, doi. 10.3109/0284186X.2015.1034877
- By:
- Publication type:
- Article
Lenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO - #077.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 2, p. 202, doi. 10.1111/bjh.12361
- By:
- Publication type:
- Article
Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with newly diagnosed/untreated multiple myeloma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2014, v. 140, n. 11, p. 1947, doi. 10.1007/s00432-014-1737-9
- By:
- Publication type:
- Article
Successful treatment of patients with newly diagnosed/untreated multiple myeloma and advanced renal failure using bortezomib in combination with bendamustine and prednisone.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2012, v. 138, n. 8, p. 1405, doi. 10.1007/s00432-012-1212-4
- By:
- Publication type:
- Article
pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104.
- Published in:
- 2014
- By:
- Publication type:
- journal article
pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-624
- By:
- Publication type:
- Article